News

Scientists have just identified a class of 'danger signals' that are highly efficient at triggering an immune response in infants and newborns. The discovery may have the potential to reduce both the age of vaccine administration and the need for multiple booster injections in infants and newborns, whose immune systems operate differently to those of adults.

A new study explains why a particular mutation in the epidermal growth factor receptor (EGFR) results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer glioblastoma multiforme (GBM).

Researchers from Case Western Reserve University School of Medicine have found a nanobody that holds promise to advance targeted therapies for a number of neurological diseases and cancer.

Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.

Hires protein analysis expert for customer support.

Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine.

Researchers describe how acidity turns oxygen-starved cancer cells dormant and drug resistant—and a potentially easy way reverse the effect.

A novel cell model for studying the impact of the immune system on neuronal repair processes in Alzheimer’s disease

Biogazelle is pleased to announce the appointment of Armin Winands as its new
CEO effective 1st July 2018, following Jan Hellemans who will take on the role of CTO after 10 years as CEO.

Scientists have revealed that immune cells called natural killer (NK) cells may play a key role in ridding the body of malaria-infected blood cells.